Cambridge, MA, United States of America

Thomas Zabawa

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 8.0

ph-index = 4

Forward Citations = 80(Granted Patents)


Location History:

  • Boston, MA (US) (2016 - 2020)
  • Cambridge, MA (US) (2018 - 2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):

Title: Celebrating the Innovative Contributions of Thomas Zabawa

Introduction: Thomas Zabawa, an accomplished inventor based in Cambridge, MA, has made significant strides in the field of pharmaceutical technology. With a remarkable portfolio of 12 patents, his contributions focus primarily on lipid compositions that enhance the delivery of active agents to cells and tissues. His work is critical in advancing therapeutic solutions in medicine.

Latest Patents: Among his latest patents are groundbreaking advancements in lipid technology. One notable invention is titled "Lipids and lipid compositions for the delivery of active agents." This patent introduces a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein various components such as R-R, L, n, and p are defined. The compounds designated in his patent are cationic lipids that are instrumental in the effective delivery of biologically active agents to target cells and tissues.

Career Highlights: Thomas Zabawa has built a distinguished career within the pharmaceutical sector, currently contributing his expertise at Novartis AG. His innovative spirit and dedication to research have positioned him as a key player in the development of new drug delivery systems, enhancing the efficacy of treatments administered to patients.

Collaborations: During his career, Thomas has collaborated with notable colleagues, including Gabriel Grant Gamber and Luis Brito. These collaborations reflect his commitment to working with talented individuals in the field to push the boundaries of innovation in drug delivery technologies.

Conclusion: Thomas Zabawa's work is a testament to the impact of dedicated inventors in scientific research and development. His patents not only showcase his brilliance as an inventor but also hold the promise of improved therapeutic strategies in the medical field. As he continues to innovate at Novartis AG, the future of drug delivery systems looks brighter, all thanks to his contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…